Shanghai MicroPort EP MedTech Co., Ltd.

Clinical trials sponsored by Shanghai MicroPort EP MedTech Co., Ltd., explained in plain language.

Shanghai MicroPort EP MedTech Co., Ltd. 688351 SSE

A subsidiary of MicroPort Scientific, focused on cardiac electrophysiology medical devices.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Not yet recruiting 1 Not yet finished but already full! 1

New heart ablation tool tested in humans for first time

Disease control By invitation only

This early study tests a new catheter that uses two types of energy (radiofrequency and pulsed field) to treat rapid heartbeats from the lower chambers. Ten adults with drug-resistant ventricular arrhythmias will receive the procedure. The main goal is to check safety and see if …

Sponsor: Shanghai MicroPort EP MedTech Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

Shanghai MicroPort EP MedTech Co., Ltd.

New heart ablation tool tested in humans for first time